Trials / Completed
CompletedNCT00233766
Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)
An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX)
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the performance and safety of two reduced sirolimus doses on the Bx VELOCITY Balloon-Expandable stent, mounted on the Raptorâ rapid exchange (RX) Stent Delivery System (SDS) in patients with de novo native coronary artery lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bx VELOCITY Stent containing 45% and 70% of Sirolimus dose |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2005-10-06
- Last updated
- 2008-04-24
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00233766. Inclusion in this directory is not an endorsement.